Clinical observation on treatment of 32 patients with measles by Qingzhen Decoction (清疹汤)

Sheng-jie Zhang; Chun-fang Wang; Yan-yan Qi; Jian-jie Chen

doi:10.1007/s11655-009-0389-0

Your Location：

Home >

Browse articles >

Clinical observation on treatment of 32 patients with measles by Qingzhen Decoction (清疹汤)

OriginalPaper | Updated：2021-08-27

- Clinical observation on treatment of 32 patients with measles by Qingzhen Decoction (清疹汤)
- Clinical observation on treatment of 32 patients with measles by Qingzhen Decoction (清疹汤)
- 中国结合医学杂志（英文版） 2009年15卷第5期页码：389-392
- Affiliations：
  
  Shanghai Pudong Infectious Disease Hospital,Shanghai,China
- Author bio：
- Funds：
  
  Supported by the Fund for High-level Characteristic Development Projects of Shanghai Education Committee [No. Shanghai Education Finance (2005) 81];the Grant from Shanghai Strengthens the Public Health System to Construct Three-year Planning for Action Items of Basic Construction Subsidization
- DOI：10.1007/s11655-009-0389-0
  中图分类号：
- 纸质出版日期：2009，
  
  网络出版日期：2009-10-3，
Scan for full text
Zhang, Sj., Wang, Cf., Qi, Yy. et al. Clinical observation on treatment of 32 patients with measles by Qingzhen Decoction (清疹汤)., Chin. J. Integr. Med. 15, 389–392 (2009). https://doi.org/10.1007/s11655-009-0389-0

Sheng-jie Zhang, Chun-fang Wang, Yan-yan Qi, et al. Clinical observation on treatment of 32 patients with measles by Qingzhen Decoction (清疹汤)[J]. Chinese Journal of Integrative Medicine, 2009,15(5):389-392.
Zhang, Sj., Wang, Cf., Qi, Yy. et al. Clinical observation on treatment of 32 patients with measles by Qingzhen Decoction (清疹汤)., Chin. J. Integr. Med. 15, 389–392 (2009). https://doi.org/10.1007/s11655-009-0389-0 DOI：

Sheng-jie Zhang, Chun-fang Wang, Yan-yan Qi, et al. Clinical observation on treatment of 32 patients with measles by Qingzhen Decoction (清疹汤)[J]. Chinese Journal of Integrative Medicine, 2009,15(5):389-392. DOI： 10.1007/s11655-009-0389-0.

摘要

To observe the clinical effect of Qingzhen Decoction (清疹汤

QZD) on measles. Methods: Adopting the randomizing digital table

62 patients with measles were assigned to two groups

32 in the treated group and 30 in the control group. All patients were treated with routine therapy

but QZD was given to the treated group additionally for 5 days. Changes of clinical symptoms

blood routine and liver function before and after treatment were observed

and the medical cost was calculated. After the 5-day treatment

the normalization rate of irritative cough in the treated and the control group was 88.9% (24/27) and 56.0% (14/25) respectively

that of conjunctival congestion was 90.0% (27/30) and 65.5% (19/29) respectively

showing significant differences between groups (P<0.05). The liver function normalization rate in the two groups was 28.6% (2/7) and 25.0% (2/8)

and the average medical cost ¥740.7 and ¥749.3

respectively. The total effective rate in the two groups was 96.9% and 93.3% respectively

showing insignificant difference between groups (P>0.05). QZD could actively improve the respiratory symptoms like irritative cough and the inflammatory symptoms of eye like conjunctival congestion in patients with measles.

Abstract

To observe the clinical effect of Qingzhen Decoction (清疹汤

QZD) on measles. Methods: Adopting the randomizing digital table

62 patients with measles were assigned to two groups

32 in the treated group and 30 in the control group. All patients were treated with routine therapy

but QZD was given to the treated group additionally for 5 days. Changes of clinical symptoms

blood routine and liver function before and after treatment were observed

and the medical cost was calculated. After the 5-day treatment

the normalization rate of irritative cough in the treated and the control group was 88.9% (24/27) and 56.0% (14/25) respectively

that of conjunctival congestion was 90.0% (27/30) and 65.5% (19/29) respectively

showing significant differences between groups (P<0.05). The liver function normalization rate in the two groups was 28.6% (2/7) and 25.0% (2/8)

and the average medical cost ¥740.7 and ¥749.3

respectively. The total effective rate in the two groups was 96.9% and 93.3% respectively

关键词

measlestreatmentChinese MedicineQingzhen Decoction

Keywords

measlestreatmentChinese MedicineQingzhen Decoction

references

Peng WW, ed. Lemology. 6th ed. Beijing: People’s Medical Publishing House; 2004:85–86.

Li MD, Wang YM, eds. Practice of infectious diseases. 6th ed. Beijing: People’s Medical Publishing House; 2005:308–309.

Zhang AJ, Lu YJ. Analysis of epidemiology and clinical features in 477 cases of measles. Chin J Microecol (Chin) 2008;20:410–412.

Zheng XY, ed. Guiding principle of clinical research on new drugs of TCM. Beijing: China Medico-Pharmaceutical Sciences and Technology Publishing House; 2002:53–272.

Shanghai Municipal Health Bureau. Guidlines for traditional Chinese medicine diagnosis and treatment of diseases and syndromes used in Shanghai. 2nd ed. Shanghai: Publishing House of Shanghai University of Traditional Chinese Medicine; 2003:264–266.

Si CW, Jia FZ, ed. Infectious diseases. Beijing: People’s Medical Publishing House; 2004:344–346.

Yang SF, Zuo LL, Chen H. Clinical analysis on 203 adult measles. J Occup Health (Chin) 2008;24:1730–1731.

Li SJ, Xu YF. Progress of research on epidemiology of measles. Shanghai J Prev Med (Chin) 2008;20:408–410.

Ji XL. Curative effect observation of modified decoction for removing meridian obstruction on adult measles combined with routine Western medicine. Shanxi J Tradit Chin Med (Chin) 2008;24:19–20.

FULL TEXT LINK

More>

浏览量

358

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Evidence-based therapies of Chinese medicine for chronic urticaria: Where do we stand and where are we going?

Idiosyncratic drug-induced liver injury linked to Polygonum multiflorum: A case study by pharmacognosy

Guidelines for the Diagnosis and Management of Herb-Induced Liver Injury

Future view and development of immunology: Exploring the immunology based on Chinese medicine and culture

Cost-effectiveness analysis of combined Chinese medicine and Western medicine for ischemic stroke patients